Industry

DAE refutes report on cancer deaths in its atomic energy hubs

19 Sep 2014

Indian Pharma regulator cuts prices of 43 drug formulations

Indian Pharma regulator cuts prices of 43 drug formulations

19 Sep 2014

The price cuts will make formulations used to treat infections and gastro intestinal disorders, a few vaccines, and commonly used antibiotics such as Ciprofloxacin HCl, Cloxacillin and Rifampicin, cheaper by up to 50 per cent

Parsvnath sells Gurgaon township development rights to Supertech

19 Sep 2014

Sinha diary: Bhushan tells SC he won’t disclose source

Sinha diary: Bhushan tells SC he won’t disclose source

18 Sep 2014

Lawyer Prashant Bhushan, who has filed a public interest suit against CBI director Ranjit Sinha, today refused a Supreme Court directive to reveal the name of the whistleblower who provided him with Sinha’s residential guest book

CCI clears Zuari’s proposal to acquire 26% stake in Mangalore Chemicals and Fertilisers

17 Sep 2014

WikiLeaks founder Julian Assange reveals bits from his forthcoming book

17 Sep 2014

Secretaries panel recommends 50% hike in gas price: report

17 Sep 2014

Sky Deutschland AG declines to recommend British Sky offer

17 Sep 2014

Status quo on Iran’s nuclear facilities not acceptable: US

17 Sep 2014

Xi effect: ‘Big B’ may make movie with Jackie Chan

17 Sep 2014

TV still leads India’s entertainment & media industry, but internet growth faster

TV still leads India’s entertainment & media industry, but internet growth faster

17 Sep 2014

Internet access and internet advertising have been the fastest-growing segments, with annual growth rates of 47 per cent and 26 per cent respectively.

TV still leads India’s entertainment & media industry, but internet growth faster

TV still leads India’s entertainment & media industry, but internet growth faster

17 Sep 2014

Internet access and internet advertising have been the fastest-growing segments, with annual growth rates of 47 per cent and 26 per cent respectively.

HC dismisses plea for CBI probe of Robert Vadra’s land deals

16 Sep 2014

New York attorney general Eric Scheiderman sues Actavis Plc over Alzheimer drug switch

16 Sep 2014

TUI Travel to merge with parent to create £5.2-bn tourism giant

TUI Travel to merge with parent to create £5.2-bn tourism giant

16 Sep 2014

The merger would see TUI Travel, which serves 30 million customers join TUI AG, owner of 230 hotels and seven cruise ships

Oil ministry extends deadline for comments on draft revenue sharing model till 20 September

15 Sep 2014

Gilead licenses its Hepatitis C drug to 7 Indian generic pharma companies

15 Sep 2014

Real estate transactions go online

Real estate transactions go online

15 Sep 2014

In the last couple of years, real estate sector has seen the emergence of websites as a low-cost tool to connect buyers and sellers. By Advitiya Sharma, co-founder and marketing head, housing.com

China creates special smartphone lanes for pedestrians to prevent them from bumping into each other

15 Sep 2014

US healthcare conglomerate Danaher Corp to buy Nobel Biocare Holding AG for $2.2 bn

15 Sep 2014

China’s Sinopec to sell $17.5-bn stake in retail business

15 Sep 2014

Reveal source of ‘Sinha diaries’, SC tells Prashant Bhushan

Reveal source of ‘Sinha diaries’, SC tells Prashant Bhushan

15 Sep 2014

CBI director Ranjit Sinha has consistently maintained that the log of visitors at his residence provided by activist Supreme Court lawyer Prashant Bhushan to the SC is a forgery, with 90 per cent of the entries forged

Vu Televisions launches aggressively-priced Ultra HD TVs

13 Sep 2014

US judge upholds Ranbaxy-Pfizer Lipitor marketing deal

US judge upholds Ranbaxy-Pfizer Lipitor marketing deal

13 Sep 2014

In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor

US judge upholds Ranbaxy-Pfizer Lipitor marketing deal

US judge upholds Ranbaxy-Pfizer Lipitor marketing deal

13 Sep 2014

In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers